You are here

Meningococcal vaccine study in Adults

The Vaccine & Immunisation Research Group of the Murdoch Childrens Research Institute in collaboration with The University of Melbourne is conducting a research study on a vaccine against meningococcal type A,C,W,Y infections in healthy adults between 18 and 40 years.

What is meningococcal disease?

Neisseria meningitidis or meningococcus is a family of germs (bacteria) that can cause meningitis, which is an infection of the surface of the brain. While meningitis is a rare infection, it can be life-threatening and lead to permanent disability.

These bacteria can also cause an infection of the blood, called sepsis. The most common groups in the meningococcus family that can cause disease are groups A, B, C, W and Y.

What is the study about?

This study is comparing the body’s ability to produce antibodies against the study vaccines, as well as the safety of a new liquid formulation of the MenACWY vaccine with a registered MenACWY vaccine.

972 people between 18 and 40 years of age will take part in the study including ~170 in Australia

Who can participate?

Participants must be:

  • Aged 18 - 40 years
  • Healthy
 

If you join the study:

  • You will receive one dose of either the MenACWY liquid study vaccine or a registered MenACWY vaccine by injection.
  • You will need to visit the study site a total of two times,  one month apart and have a phone call at 2 weeks, 3 months and 6 months after vaccination.

For more information contact us: